Key result
Dabigatran etexilate was used to prevent warfarin-induced skin necrosis in a patient with severe protein C deficiency.
Why the study?
Does dabigatran etexilate prevent warfarin-induced skin necrosis in a patient with severe protein C deficiency?
Does dabigatran etexilate prevent warfarin-induced skin necrosis in a patient with severe protein C deficiency?
Answers are grounded in this paper and cite their sources.
Dabigatran etexilate may be considered for preventing warfarin-induced skin necrosis in patients with severe protein C deficiency.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hermans et al. (2012) studied this question. Dabigatran etexilate was used to prevent warfarin-induced skin necrosis in a patient with severe protein C deficiency.
Synapse has enriched 10 related papers. Consider them for comparative context: